Real-world Data Analysis of REN Treatment in Adolescence with Migraine

CompletedOBSERVATIONAL
Enrollment

1,629

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

August 15, 2022

Study Completion Date

August 24, 2022

Conditions
Migraine in Adolescence
Interventions
DEVICE

Nerivio

Remote electrical neuromodulation (REN) device for the acute treatment of migraines. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation(CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application.

Trial Locations (2)

4250438

Theranica Bio-Electronics Ltd, Netanya

08807

Theranica USA Inc, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT05443659 - Real-world Data Analysis of REN Treatment in Adolescence with Migraine | Biotech Hunter | Biotech Hunter